Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma

NCT00522405 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences as lead sponsor.

NCT NCT00522405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00522405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma
Lead sponsor
All India Institute of Medical Sciences
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2007
Completion date
October 31, 2014
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma